GlassScriptPhysician profile
Nathan Ward Baldwin
NPI 1235279688
$2,037.47
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $382 · 2021: $443 · 2022: $388 · 2023: $309 · 2024: $81.95 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $700.68 | 2019-2025 | Breztri, Farxiga |
| Abbvie INC. | $578.57 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $261.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $148.48 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.29 | 2019-2020 | |
| Glaxosmithkline, LLC. | $53.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.65 | 2019-2020 | |
| Allergan, INC. | $38.29 | 2020 | |
| Idorsia Pharmaceuticals US INC | $28.27 | 2023 | Quviviq |
| Sanofi Pasteur INC. | $26.81 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.86 | 2023 | |
| Genentech USA, INC. | $24.23 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $16.11 | 2023 | Qelbree |
| Amarin Pharma, INC. | $14.94 | 2020 | |
| Tris Pharma INC | $12.92 | 2023 | Dyanavel Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.